Raynaud's phenomenon in systemic lupus erythematosus. 1995

L T Lavras Costallat, and A M Valente Coimbra
Department of Internal Medicine, State University of Campinas, Sao Paulo, Brazil.

OBJECTIVE To determine the frequency and nature of clinical manifestations in Brazilian patients with systemic lupus erythematosus and Raynaud's phenomenon. METHODS One hundred twenty-three patients with systemic lupus erythematosus (1982 American Rheumatism Association criteria) and Raynaud's phenomenon (at least two-phase, bilateral color reaction reported by the patient or observed by a physician) referred to the Rheumatology Unit of the Campinas University Hospital were retrospectively compared with 149 systemic lupus erythematosus patients without Raynaud's phenomenon. For each patient, gender, race, age at disease onset, disease duration, follow-up duration, clinical manifestations, and laboratory test findings were recorded. RESULTS Patients with Raynaud's phenomenon were more likely to have skin lesions and/or myalgia/myopathy and less likely to have nephritis and nephrotic syndrome. All five patients with pulmonary hypertension also had Raynaud's phenomenon. Raynaud's phenomenon was less common in younger patients and more common in patients with alopecia. CONCLUSIONS Raynaud's phenomenon was common in systemic lupus erythematosus patients from a tropical country. A better prognosis can be expected in lupus patients with Raynaud's phenomenon except when pulmonary hypertension occurs.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011928 Raynaud Disease An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress. Cold Fingers, Hereditary,Raynaud Phenomenon,Raynaud's Disease,Raynauds Disease
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age

Related Publications

L T Lavras Costallat, and A M Valente Coimbra
January 2015, Anais brasileiros de dermatologia,
L T Lavras Costallat, and A M Valente Coimbra
May 1981, Bratislavske lekarske listy,
L T Lavras Costallat, and A M Valente Coimbra
January 1985, Dermatologica,
L T Lavras Costallat, and A M Valente Coimbra
August 1979, Arthritis and rheumatism,
L T Lavras Costallat, and A M Valente Coimbra
January 2009, Annales Academiae Medicae Stetinensis,
L T Lavras Costallat, and A M Valente Coimbra
January 1984, Terapevticheskii arkhiv,
L T Lavras Costallat, and A M Valente Coimbra
March 2000, Lancet (London, England),
L T Lavras Costallat, and A M Valente Coimbra
April 2013, Rheumatology international,
L T Lavras Costallat, and A M Valente Coimbra
May 1988, Journal of the National Medical Association,
Copied contents to your clipboard!